Zemla TJ - Search Results

1

GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian Patients.

Nartey YA, Yang JD, Zemla TJ, Ayawin J, Asibey SO, El-Kassas M, Bampoh SA, Duah A, Agyei-Nkansah A, Awuku YA, Afihene MY, Yamada H, Yin J, Plymoth A, Roberts LR. Nartey YA, et al. Among authors: zemla tj. Cancer Res Commun. 2024 Oct 1;4(10):2653-2659. doi: 10.1158/2767-9764.CRC-24-0227. Cancer Res Commun. 2024. PMID: 39324700 Free PMC article.

2

Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501).

Snyder RA, Zemla TJ, Shi Q, Segovia D, Ahmad SA, O'Reilly EM, Herman JM, Katz MHG. Snyder RA, et al. Among authors: zemla tj. Ann Surg Oncol. 2024 Oct;31(10):7033-7042. doi: 10.1245/s10434-024-15670-6. Epub 2024 Jul 15. Ann Surg Oncol. 2024. PMID: 39008208 Clinical Trial.

3

Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study.

Storandt MH, Zemla TJ, Patell K, Naleid N, Gile JJ, Tran NH, Chakrabarti S, Jin Z, Borad M, Mahipal A. Storandt MH, et al. Among authors: zemla tj. Oncologist. 2024 Nov 4;29(11):986-996. doi: 10.1093/oncolo/oyae142. Oncologist. 2024. PMID: 38979643 Free PMC article.

4

Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance).

Nakasone ES, Zemla TJ, Yu M, Lin SY, Ou FS, Carter K, Innocenti F, Saltz L, Grady WM, Cohen SA. Nakasone ES, et al. Among authors: zemla tj. Epigenetics. 2024 Dec;19(1):2349980. doi: 10.1080/15592294.2024.2349980. Epub 2024 May 8. Epigenetics. 2024. PMID: 38716804 Free PMC article. Clinical Trial.

5

Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas.

Tchelebi LT, Segovia D, Smith K, Shi Q, Fitzgerald TJ, Chuong MD, Zemla TJ, O'Reilly EM, Meyerhardt JA, Koay EJ, Lowenstein J, Shergill A, Katz MHG, Herman JM. Tchelebi LT, et al. Among authors: zemla tj. Int J Radiat Oncol Biol Phys. 2024 Sep 1;120(1):111-119. doi: 10.1016/j.ijrobp.2024.03.013. Epub 2024 Mar 15. Int J Radiat Oncol Biol Phys. 2024. PMID: 38492812 Free PMC article. Clinical Trial.

6

HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.

Battaglin F, Ou FS, Qu X, Hochster HS, Niedzwiecki D, Goldberg RM, Mayer RJ, Ashouri K, Zemla TJ, Blanke CD, Venook AP, Kabbarah O, Lenz HJ, Innocenti F. Battaglin F, et al. Among authors: zemla tj. J Clin Oncol. 2024 Jun 1;42(16):1890-1902. doi: 10.1200/JCO.23.01507. Epub 2024 Mar 8. J Clin Oncol. 2024. PMID: 38457761 Clinical Trial.

7

SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.

Martini A, Prasai K, Zemla TJ, Ahmed FY, Elnagar MB, Giama NH, Guzzardo V, Biasiolo A, Fassan M, Yin J, Pontisso P, Roberts LR. Martini A, et al. Among authors: zemla tj. Cancers (Basel). 2024 Jan 3;16(1):225. doi: 10.3390/cancers16010225. Cancers (Basel). 2024. PMID: 38201652 Free PMC article.

8

Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study.

Palmer ME, Gile JJ, Storandt MH, Jin Z, Zemla TJ, Tran NH, Mahipal A. Palmer ME, et al. Among authors: zemla tj. Cancers (Basel). 2023 Oct 6;15(19):4867. doi: 10.3390/cancers15194867. Cancers (Basel). 2023. PMID: 37835561 Free PMC article.

9

Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma.

Storandt MH, Gile JJ, Palmer ME, Zemla TJ, Ahn DH, Bekaii-Saab TS, Jin Z, Tran NH, Mahipal A. Storandt MH, et al. Among authors: zemla tj. Cancers (Basel). 2022 Oct 22;14(21):5173. doi: 10.3390/cancers14215173. Cancers (Basel). 2022. PMID: 36358592 Free PMC article.

10

Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.

Gile JJ, Wookey V, Zemla TJ, Shi Q, Jin Z, Alberts SR, McWilliams RR, Ma WW, Borad M, Bekaii-Saab TS, Tran NH, Mahipal A. Gile JJ, et al. Among authors: zemla tj. Target Oncol. 2022 Sep;17(5):529-538. doi: 10.1007/s11523-022-00914-w. Epub 2022 Sep 2. Target Oncol. 2022. PMID: 36056231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters